Magic mushrooms and Alzheimer’s: what one remarkable case can tell us
Magic mushrooms are better known for producing hallucinations and altering people’s sense of reality than for treating brain diseases. Most people associate them with tripping, rather than Alzheimer’s disease.
But a report on an individual patient has prompted scientists to ask whether psilocybin, the psychedelic compound in magic mushrooms, could have unexpected effects on the ageing brain.
The report describes changes observed in a Japanese-American woman in her 80s with advanced Alzheimer’s disease after she received psilocybin-containing mushrooms. Dementia is a broad term for symptoms that affect memory, thinking and everyday independence. Alzheimer’s disease is its most common cause.
The woman had experienced progressive decline for a decade. For the previous five years, she had largely communicated using single words and relied heavily on others for everyday care. She also had difficulty walking and dressing herself and experienced chronic urinary incontinence.
She received 5g of psilocybin-containing mushrooms. The exact amount of psilocybin is unclear because mushroom potency varies. During the experience, she sweated heavily and entered a prolonged sleep-like state. Around 19 hours later, she began speaking spontaneously and recalling memories from her own life.
Over the following days and weeks, caregivers reported that she seemed more alert, recognised family members, walked more independently, began dressing herself and regained urinary continence. One month later, she received a second supervised session involving 3g of........
